|
|
| (16 intermediate revisions by 11 users not shown) |
| label / ast | label / ast |
| | | Modes of resistance to anti-angiogenic therapy |
| description / hy | description / hy |
| գիտական հոդված | | 2008 թվականի օգոստոսին հրատարակված գիտական հոդված |
| description / ast | description / ast |
| artículu científicu | | artículu científicu espublizáu en 2008 |
| description / pt-br | description / pt-br |
| artigo científico | | artigo científico (publicado na 2008) |
| description / uk | description / uk |
| наукова стаття | | наукова стаття, опублікована в серпні 2008 |
| description / hyw | description / hyw |
| | | 2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած |
| description / bn | description / bn |
| | | ২০০৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ |
| description / fa | description / fa |
| | | مقالهٔ علمی |
| description / ur | description / ur |
| | | سائنسی مضمون |
| Property / author name string | |
| Gabriele Bergers
| |
| Property / author name string: Gabriele Bergers / rank | |
| Normal rank
| |
| Property / author name string: Gabriele Bergers / qualifier | |
| | |
| Property / instance of |
| | | |
| Property / instance of: review article / rank |
| | | Normal rank |
| Property / instance of: review article / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival / rank |
| | | Normal rank |
| Property / cites work: Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: A phase I pharmacokinetic and pharmacodynamic study of TKI258, an oral, multitargeted receptor tyrosine kinase inhibitor in patients with advanced solid tumors / rank |
| | | Normal rank |
| Property / cites work: A phase I pharmacokinetic and pharmacodynamic study of TKI258, an oral, multitargeted receptor tyrosine kinase inhibitor in patients with advanced solid tumors / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors. / rank |
| | | Normal rank |
| Property / cites work: Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: A microenvironmental model of carcinogenesis. / rank |
| | | Normal rank |
| Property / cites work: A microenvironmental model of carcinogenesis. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes / rank |
| | | Normal rank |
| Property / cites work: Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. / rank |
| | | Normal rank |
| Property / cites work: Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Differential diagnosis of pancreatic tumors using ultrasound contrast imaging. / rank |
| | | Normal rank |
| Property / cites work: Differential diagnosis of pancreatic tumors using ultrasound contrast imaging. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Pegaptanib for neovascular age-related macular degeneration / rank |
| | | Normal rank |
| Property / cites work: Pegaptanib for neovascular age-related macular degeneration / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer. / rank |
| | | Normal rank |
| Property / cites work: A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Tumor-associated endothelial cells with cytogenetic abnormalities. / rank |
| | | Normal rank |
| Property / cites work: Tumor-associated endothelial cells with cytogenetic abnormalities. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms / rank |
| | | Normal rank |
| Property / cites work: Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival / rank |
| | | Normal rank |
| Property / cites work: Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: The hypoxic response of tumors is dependent on their microenvironment. / rank |
| | | Normal rank |
| Property / cites work: The hypoxic response of tumors is dependent on their microenvironment. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Effect of p53 status on tumor response to antiangiogenic therapy. / rank |
| | | Normal rank |
| Property / cites work: Effect of p53 status on tumor response to antiangiogenic therapy. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2. / rank |
| | | Normal rank |
| Property / cites work: Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Pegaptanib sodium for the treatment of age-related macular degeneration / rank |
| | | Normal rank |
| Property / cites work: Pegaptanib sodium for the treatment of age-related macular degeneration / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: The Delta paradox: DLL4 blockade leads to more tumour vessels but less tumour growth / rank |
| | | Normal rank |
| Property / cites work: The Delta paradox: DLL4 blockade leads to more tumour vessels but less tumour growth / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Randomized phase II trial of cetuximab, bevacizumab, and irinotecan compared with cetuximab and bevacizumab alone in irinotecan-refractory colorectal cancer: the BOND-2 study / rank |
| | | Normal rank |
| Property / cites work: Randomized phase II trial of cetuximab, bevacizumab, and irinotecan compared with cetuximab and bevacizumab alone in irinotecan-refractory colorectal cancer: the BOND-2 study / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Antiangiogenic therapy for cancer: an update / rank |
| | | Normal rank |
| Property / cites work: Antiangiogenic therapy for cancer: an update / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: A cancer therapy resistant to resistance / rank |
| | | Normal rank |
| Property / cites work: A cancer therapy resistant to resistance / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Therapeutic implications of intrinsic or induced angiogenic growth factor redundancy in tumors revealed / rank |
| | | Normal rank |
| Property / cites work: Therapeutic implications of intrinsic or induced angiogenic growth factor redundancy in tumors revealed / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Sustained VEGF blockade results in microenvironmental sequestration of VEGF by tumors and persistent VEGF receptor-2 activation / rank |
| | | Normal rank |
| Property / cites work: Sustained VEGF blockade results in microenvironmental sequestration of VEGF by tumors and persistent VEGF receptor-2 activation / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis / rank |
| | | Normal rank |
| Property / cites work: Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells / rank |
| | | Normal rank |
| Property / cites work: VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells / rank |
| | | Normal rank |
| Property / cites work: SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells / reference |
| | | |
| Property / Dimensions Publication ID |
| | | |
| Property / Dimensions Publication ID: 1013847179 / rank |
| | | Normal rank |
| Property / main subject |
| | | |
| Property / main subject: angiogenesis inhibitor / rank |
| | | Normal rank |
| Property / main subject: angiogenesis inhibitor / reference |
| | | |
| Property / author |
| | | |
| Property / author: Gabriele Bergers / rank |
| | | Normal rank |
| Property / author: Gabriele Bergers / qualifier |
| | | |
| Property / author: Gabriele Bergers / qualifier |
| | | |
